Skip to main content

Animations

MJFF Publications

7911 - 7920 of 9148 Results
Title
Year
  • Year
  • 2021
  • 2026
  • 2025
  • 2025
  • 2018
  • 2021
  • 2021
  • 2015
  • 2014
  • 2019
  • Summary Details
    OPEN
    Title: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001
    Citation Count: 103
  • Summary Details
    OPEN
    Title: DNAJC13 Variants Show No Robust Association With Parkinson's Disease in a Multiancestry Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70429
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Multi-parameter fluorescence lifetime imaging for high-noise neuroscience applications
    Journal Name: Biomedical Optics Express
    Publisher: Optica Publishing Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1364/boe.578337
    Citation Count: 0
  • Summary Details
    OPEN
    Title: It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of Life
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70134
    Citation Count: 1
  • Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
    2018
    Summary Details
    RESTRICTED
    Title: Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27492
    Citation Count: 205
  • Summary Details
    OPEN
    Title: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddab058
    Citation Count: 36
  • Summary Details
    OPEN
    Title: In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brainres.2021.147503
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Constructing de Novo H2O2 Signaling via Induced Protein Proximity
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.5b00170
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027
    Citation Count: 141
  • Summary Details
    OPEN
    Title: Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlz080
    Citation Count: 88
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.